Vor Biopharma Inc. has announced a key management change with the appointment of Robert Ang, the company's President and Chief Executive Officer, as the new principal financial officer and principal accounting officer. The decision was made by the Board of Directors on May 19, 2024. Dr. Ang, who is also a director of the company, will now assume additional responsibilities in overseeing the company's financial and accounting functions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-123141), on May 20, 2025, and is solely responsible for the information contained therein.